Overview
Investors 5
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| UCB Ventures | ucbventures.com | |
| The Column Group | thecolumngroup.com | |
| Mar 8, 2024 | Ysios Capital | ysioscapital.com |
| SymBiosis | symbiosis.vc |
Funding Rounds 5
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Feb 9, 2024 | Funding round | $120M | |
| Jun 22, 2021 | Funding round | $41.5M | |
| Dec 1, 2015 | Series A round | $23.5M | |
| Dec 24, 2014 | Funding round | $7.6M |
Mentions in press and media 26
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 6, 2024 | Neurona Therapeutics Presents Positive Clinical Update: New Data from NRTX-1001 Cell Therapy Trial in Drug-resistant Epilepsy Announced at 2024 Annual Meeting of the American Epilepsy Society | San Francisco, CA, December 6, 2024 – Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for epilepsy and other disorders of the nervous system, today announced positive clinical data from t... |
| Sep 10, 2024 | Neurona Therapeutics Receives $3.8 Million CIRM Grant for the Development of Next Generation Neural Cell Therapy Candidate | SAN FRANCISCO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for disorders of the nervous system, today announced that the California Institute for Re... |
| Mar 12, 2024 | Neurona Therapeutics to Present at Stifel 2024 Virtual CNS Days | |
| Mar 12, 2024 | Neurona Therapeutics to Present at Stifel 2024 Virtual CNS Days | SAN FRANCISCO, March 12, 2024 (GLOBE NEWSWIRE) -- Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapy candidates for the treatment of neurological disorders, today announced that Cory R. Nichol... |
| Mar 7, 2024 | Neurona Therapeutics Announces Presentation of Updated Clinical Data at the Upcoming American Academy of Neurology (AAN) Annual Meeting from Lead Cell Therapy Candidate, NRTX-1001 | |
| Feb 9, 2024 | Ysios Capital invierte en la Serie E de 120 millones de dólares de Neurona Therapeutics | 09/02/2024 Nota de prensa YSIOS CAPITAL INVIERTE EN LA SERIE E DE 120 MILLONES DE DÓLARES DE NEURONA THERAPEUTICS Ysios Capital, gestora española líder en inversiones en el sector biotecnológico, ha anunciado hoy su participación en la rond... |
| Feb 9, 2024 | Neurona Therapeutics Raises $120M in Funding | Neurona Therapeutics, a San Francisco, CA-based clinical-stage biotherapeutics company, raised $120M in funding. The round was led by Viking Global Investors and Cormorant Asset Management with participation from new and existing investors,... |
| Feb 8, 2024 | Neurona Therapeutics Lands $120M | SAN FRANCISCO, CA, Neurona Therapeutics today announced the successful completion of a $120 million financing. >> Click here for more funding data on Neurona Therapeutics >> To export Neurona Therapeutics funding data to PDF... |
| Feb 8, 2024 | Neurona Therapeutics Raises $120M to Advance Groundbreaking Pipeline of Regenerative Cell Therapy Candidates for Chronic Neurological Disorders |
Reviews 0
FAQ about Neurona Therapeutics
When was Neurona Therapeutics founded?
Neurona Therapeutics was founded in 2008.
How much funding has Neurona Therapeutics raised?
Neurona Therapeutics has raised $294.6M in total across 5 funding rounds.
What funding rounds has Neurona Therapeutics raised?
Parsers VC lists 5 funding rounds of Neurona Therapeutics, among them a funding round of $120M on Feb 9, 2024, a funding round of $41.5M on Jun 22, 2021 and a Series A round of $23.5M on Dec 1, 2015.
Who has invested in Neurona Therapeutics?
Parsers VC lists 5 investors of Neurona Therapeutics, among them Ysios Capital, UCB Ventures and The Column Group.
What has the press written about Neurona Therapeutics?
Parsers VC has collected 26 articles mentioning Neurona Therapeutics, among them “Neurona Therapeutics Presents Positive Clinical Update: New Data from NRTX-1001 Cell Therapy Trial in Drug-resistant Epilepsy Announced at 2024 Annual Meetin...” (Dec 6, 2024) and “Neurona Therapeutics Receives $3.8 Million CIRM Grant for the Development of Next Generation Neural Cell Therapy Candidate” (Sep 10, 2024).
Is Neurona Therapeutics still active?
Yes, Neurona Therapeutics is active; its latest activity on Parsers VC dates from Apr 3, 2025.